MyBlueDotsMeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR MyBlueDots4 weeks ago01 mins ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #AMR–These new members bring decades of experience in medicine, industry, and healthcare policy, strengthening MeMed’s work in host-response technologies. Post navigation Previous: Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025Next: Syringe exchange fears hobble fight against West Virginia HIV outbreak
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots8 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots8 hours ago 0